Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Cancer|May 19, 2026
Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistanceHui Tang, Ping Xie, Jihae Ahn, et al.
GEN Biotechnology|June 26, 2023
Comparative Evaluation of Synthetic Cytokines for Enhancing Production and Performance of NK92 Cell-Based TherapiesSimrita Deol, Patrick S Donahue, Roxana E Mitrut, et al.
Frontiers in Immunology|August 1, 2020
Development of Spherical Nucleic Acids for Prostate Cancer ImmunotherapyLei Qin, Shuya Wang, Donye Dominguez, et al.
The Journal of Clinical Investigation|April 3, 2025
4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor responseJihae Ahn, Ping Xie, Siqi Chen, et al.
Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.
The Journal of Clinical Investigation|March 5, 2024
CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione/GPX4Siqi Chen, Jie Fan, Ping Xie, et al.
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Blood|April 18, 2014
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesisRaajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, et al.
The Journal of Experimental Medicine|August 3, 2016
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosisSrdan Verstovsek, Taghi Manshouri, Darrell Pilling, et al.
The Journal of Clinical Investigation|January 23, 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionAnna Sophia McKenney, Allison N Lau, Amritha Varshini Hanasoge Somasundara, et al.
Pageof 2